リプロセル is reported to have obtained a license from Kanagawa Prefecture to manufacture and market regenerative medicine products. The details were reported in a breaking-news item stating that the license was obtained on the 18th and distributed on the 24th.
リプロセル obtained a license from Kanagawa Prefecture to manufacture and market regenerative medicine products. Related reports state that the license was obtained on the 18th.
The article explains that the full text can be viewed after registering with the VIP Club.